(Q34074668)

English

Ascomycins: promising agents for the treatment of inflammatory skin diseases

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

title

Ascomycins: promising agents for the treatment of inflammatory skin diseases (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

30 July 2017

0 references

C Paul

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11060661

retrieved

30 July 2017

M Graeber

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11060661

retrieved

30 July 2017

A Stuetz

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11060661

retrieved

30 July 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11060661

retrieved

30 July 2017

published in

Expert Opinion on Investigational Drugs

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11060661

retrieved

30 July 2017

volume

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11060661

retrieved

30 July 2017

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11060661

retrieved

30 July 2017

page(s)

69-77

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11060661

retrieved

30 July 2017

cites work

A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F13543784.9.1.69

retrieved

21 January 2018

A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F13543784.9.1.69

retrieved

21 January 2018

Ascomycin macrolactam derivative SDZ ASM 981 inhibits the release of granule-associated mediators and of newly synthesized cytokines in RBL 2H3 mast cells in an immunophilin-dependent manner

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F13543784.9.1.69

retrieved

21 January 2018

Identifiers

DOI

10.1517/13543784.9.1.69

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11060661

retrieved

30 July 2017

PubMed publication ID

11060661

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11060661

retrieved

30 July 2017

(Q34074668)

Ascomycins: promising agents for the treatment of inflammatory skin diseases

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)